Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Tenofovir Disoproxil Fumarate Patent Expiration

Tenofovir Disoproxil Fumarate is used for managing chronic hepatitis B and HIV infections in both adults and pediatric patients. It was first introduced by Gilead Sciences Inc in its drug Viread on Oct 26, 2001. 12 different companies have introduced drugs containing Tenofovir Disoproxil Fumarate.


Tenofovir Disoproxil Fumarate Patents

Given below is the list of patents protecting Tenofovir Disoproxil Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Viread US5922695

(Pediatric)

 Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability Jan 25, 2018

(Expired)

 Gilead Sciences Inc
Viread US5935946

(Pediatric)

 Nucleotide analog composition and synthesis method Jan 25, 2018

(Expired)

 Gilead Sciences Inc
Viread US5977089

(Pediatric)

 Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Jan 25, 2018

(Expired)

 Gilead Sciences Inc
Viread US6043230

(Pediatric)

 Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Jan 25, 2018

(Expired)

 Gilead Sciences Inc
Viread US5922695 Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability Jul 25, 2017

(Expired)

 Gilead Sciences Inc
Viread US5935946 Nucleotide analog composition and synthesis method Jul 25, 2017

(Expired)

 Gilead Sciences Inc
Viread US5977089 Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Jul 25, 2017

(Expired)

 Gilead Sciences Inc
Viread US6043230 Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Jul 25, 2017

(Expired)

 Gilead Sciences Inc



Tenofovir Disoproxil Fumarate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tenofovir Disoproxil Fumarate Generic API Manufacturers

Several generic applications have been filed for Tenofovir Disoproxil Fumarate. The first generic version for Tenofovir Disoproxil Fumarate was by Teva Pharmaceuticals Usa and was approved on Mar 18, 2015. And the latest generic version is by Norvium Bioscience Llc and was approved on Feb 29, 2024.

Given below is the list of companies who have filed for Tenofovir Disoproxil Fumarate generic, along with the locations of their manufacturing plants worldwide.


1. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jan 26, 2018
150MG

tablet Prescription ORAL AB Jan 26, 2018
200MG

tablet Prescription ORAL AB Jan 26, 2018
250MG

tablet Prescription ORAL AB Jan 26, 2018


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





2. CHARTWELL

Chartwell Life Molecules Llc has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jul 26, 2018


Manufacturing Plant Locations
New

Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.

Country City Firm Name
United States
Carmel Chartwell Pharmaceuticals Carmel LLC
Congers Chartwell Life Sciences LLC
West Caldwell Chartwell Pharmaceuticals West Caldwell LLC
Richboro Chartwells Division of Compass Group / Commodities Locker
Congers Chartwell Pharmaceuticals LLC





3. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Discontinued ORAL N/A Feb 26, 2018





4. CIPLA

Cipla Ltd has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jan 26, 2018


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Bangalore Cipla Ltd.
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Vasco Da Gama Cipla Limited
Pithampur, District Dhar Cipla Limited
Bengaluru Cipla Limited
Raigad Cipla Limited
Mumbai Cipla Limited





5. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jan 26, 2018





6. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jan 26, 2018





7. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 4 different strengths of generic version for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Feb 29, 2024
150MG

tablet Discontinued ORAL N/A Nov 27, 2018
200MG

tablet Discontinued ORAL N/A Nov 27, 2018
250MG

tablet Discontinued ORAL N/A Nov 27, 2018





8. QILU

Qilu Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Qilu.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 2, 2018
250MG

tablet Prescription ORAL AB Mar 2, 2018
300MG

tablet Prescription ORAL AB Mar 2, 2018


Manufacturing Plant Locations
New

Qilu's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Qilu as present at those locations.

Country City Firm Name
China
Jinan Qilu Antibiotics Pharmaceutical Co. , Ltd.
Hohhot Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
Jinan Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
Dezhou Qilu SYNVA Pharmaceutical Co. Ltd
Hulunbeier Qilu Pharmaceutical Hulun Buir Branch
Haikou Qilu Pharmaceutical (Hainan) Co. Ltd.
Jinan Qilu Pharmaceutical Co., Ltd.





9. REYOUNG

Reyoung Corporation has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Reyoung.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Mar 2, 2023





10. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 1 generic for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Jan 26, 2018


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





11. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Tenofovir Disoproxil Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG

tablet Prescription ORAL AB Mar 18, 2015
150MG

tablet Prescription ORAL AB Jan 26, 2018
200MG

tablet Prescription ORAL AB Jan 26, 2018
250MG

tablet Prescription ORAL AB Jan 26, 2018